<DOC>
	<DOCNO>NCT01024348</DOCNO>
	<brief_summary>Extended-release tramadol indicate management moderate severe pain adult require around-the-clock treatment . It provide extended duration action , constant plasma concentration , reduce dosing frequency , potential improve compliance therapeutic outcome . The present study design evaluate safety effectiveness medication treatment early postoperative pain knee arthroscopy .</brief_summary>
	<brief_title>Safety Effectiveness Tramadex-OD After Knee Arthroscopy</brief_title>
	<detailed_description />
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Tramadol</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Men nonpregnant woman Age : 1865 year ASA classification I II ambulatory knee arthroscopy spinal anesthesia Pregnancy Intolerance opioid , tramadol paracetamol spine surgery past renal hepatic impairment cardiac respiratory condition put patient risk respiratory depression patient receive : monoamine oxidase inhibitor , carbamazepine , quinidine , selective serotonin reuptake inhibitor tricyclic antidepressant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Surgery , knee arthroscopy</keyword>
	<keyword>Pain , postoperative</keyword>
	<keyword>tramadol , extend release</keyword>
</DOC>